R Squared Ltd Makes New $103,000 Investment in Cardinal Health, Inc. (NYSE:CAH)

R Squared Ltd acquired a new stake in shares of Cardinal Health, Inc. (NYSE:CAH) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 870 shares of the company’s stock, valued at approximately $103,000.

A number of other hedge funds have also recently bought and sold shares of CAH. State Street Corp raised its holdings in Cardinal Health by 4.6% in the 3rd quarter. State Street Corp now owns 14,177,641 shares of the company’s stock valued at $1,566,913,000 after acquiring an additional 627,253 shares during the last quarter. Geode Capital Management LLC grew its position in shares of Cardinal Health by 0.7% in the third quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company’s stock valued at $633,298,000 after purchasing an additional 42,082 shares during the period. Pacer Advisors Inc. increased its stake in Cardinal Health by 4.7% in the third quarter. Pacer Advisors Inc. now owns 4,290,650 shares of the company’s stock valued at $474,203,000 after purchasing an additional 191,568 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in Cardinal Health by 2.3% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,474,625 shares of the company’s stock worth $162,976,000 after buying an additional 33,388 shares during the period. Finally, Two Sigma Advisers LP boosted its stake in Cardinal Health by 47.9% in the 3rd quarter. Two Sigma Advisers LP now owns 1,069,462 shares of the company’s stock worth $118,197,000 after buying an additional 346,362 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Stock Up 0.4 %

Shares of NYSE:CAH opened at $128.32 on Friday. The company has a 50 day moving average of $122.00 and a two-hundred day moving average of $113.85. Cardinal Health, Inc. has a 52-week low of $93.17 and a 52-week high of $132.84. The company has a market capitalization of $31.05 billion, a price-to-earnings ratio of 24.96, a price-to-earnings-growth ratio of 1.57 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.56% and a negative return on equity of 56.56%. On average, equities analysts anticipate that Cardinal Health, Inc. will post 7.82 earnings per share for the current year.

Cardinal Health Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd were paid a $0.5056 dividend. The ex-dividend date was Thursday, January 2nd. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.58%. Cardinal Health’s dividend payout ratio (DPR) is presently 39.30%.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on CAH shares. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Cardinal Health from $119.00 to $124.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Bank of America upgraded shares of Cardinal Health from a “neutral” rating to a “buy” rating and lifted their price target for the company from $132.00 to $145.00 in a report on Monday, January 6th. Citigroup upped their price objective on Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a report on Friday, January 10th. StockNews.com cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd. Finally, Mizuho started coverage on Cardinal Health in a research note on Wednesday, December 4th. They set an “outperform” rating and a $139.00 price target for the company. Four investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $135.21.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.